Here are four things to know:
• The stock was sold at an average price of $45.52, for a total transaction of $360,518.
• Mr. Miles now directly owns 91,688 shares in the company, valued at approximately $4,173,637.
• The company’s stock currently has an average rating of “buy” and an average price target of $52.27.
• NuVasive has a 52-week low of $31.35 and a 52-week high of $51.23.
More articles on devices:
DOJ extends Biomet’s deferred prosecution agreement
Oppenheimer updates Globus Medical price target — 5 key notes
Are Medtronic shares undervalued at $77 per share? 7 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
